Swiss Pharma Company – IDEOGEN takes over Special Access Program for BELEODAQ® (belinostat)

IDEOGEN GROUP, Managed Access division, takes over Special Access Program for BELEODAQ® (belinostat) in Europe, Middle East, North Africa, Russia, and CIS. BELEODAQ® is a prescription medicine used to treat patients with

Read More